Literature DB >> 22213701

Oxidation of benzyl alcohol by using gold nanoparticles supported on ceria foam.

Mosaed Alhumaimess1, Zhongjie Lin, Weihao Weng, Nikolaos Dimitratos, Nicholas F Dummer, Stuart H Taylor, Jonathan K Bartley, Christopher J Kiely, Graham J Hutchings.   

Abstract

The efficacy of using cerium oxide foams as a support for Au nanoparticles and subsequent use as oxidation catalysts have been investigated. These were synthesized using L-asparagine to produce a cerium coordination polymer foam, which was calcined to give the oxide foam. Au nanoparticles were supported on the CeO(2) foams using a sol-immobilization method. The activity of the Au/foamCeO(2) for solvent-free benzyl alcohol oxidation was superior to standard Au/CeO(2) catalysts, and the activity was found to be dependent on the crystallization time of the precursor foam. A crystallization time of 4 h was found to produce the most active catalyst, which retained activity and a high selectivity to benzaldehyde (ca. 96 %) when re-used and this is related to the structure of the material. The high activity is attributed to the greater lability of surface oxygen in the support compared with commercial CeO(2) materials.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22213701     DOI: 10.1002/cssc.201100374

Source DB:  PubMed          Journal:  ChemSusChem        ISSN: 1864-5631            Impact factor:   8.928


  2 in total

1.  Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland.

Authors:  Joanna Mangana; Phil F Cheng; Corina Kaufmann; Valerie C Amann; Anna L Frauchiger; Viola Stögner; Ulrike Held; Roger von Moos; Olivier Michielin; Ralph P Braun; Mitchell P Levesque; Simone M Goldinger; Reinhard Dummer
Journal:  Melanoma Res       Date:  2017-08       Impact factor: 3.599

2.  Effect of synthesis pH on the structure and catalytic properties of FeMo catalysts.

Authors:  Shuai Zhang; Minghan Han
Journal:  RSC Adv       Date:  2019-12-17       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.